TY  - GEN
AU  - Tibes,Raoul
AU  - Mesa,Ruben A
TI  - Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?
SN  - 1029-2403
PY  - 2011///1031
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Humans
KW  - Janus Kinase 2
KW  - antagonists & inhibitors
KW  - Leukemia
KW  - drug therapy
KW  - Mutation
KW  - genetics
KW  - Myeloproliferative Disorders
KW  - Neoplasm Staging
KW  - Primary Myelofibrosis
KW  - Protein Kinase Inhibitors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.3109/10428194.2011.566952
ER  -